Chiniara Ellen has filed 14 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 90000 shares of Compass Therapeutics, Inc. ($CMPX) on January 02, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Compass Therapeutics, Inc. | $CMPX | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 177,862,102 | 9999.99% | 0.05% |
| March 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 75,043,991 | 9999.99% | 0.07% |
| March 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | A | Common Stock | 27500 | $0.00 | 82,326.0000 | 75,043,991 | 50.16% | 0.04% |
| March 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | S | Common Stock | 1833 | $30.33 | 80,493.0000 | 75,043,991 | 2.23% | 0.00% |
| March 3, 2025 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | S | Common Stock | 408 | $31.00 | 80,085.0000 | 75,043,991 | 0.51% | 0.00% |
| Feb. 11, 2025 | Compass Therapeutics, Inc. | $CMPX | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | S | Common Stock | 3129 | $41.75 | 54,826.0000 | 75,043,991 | 5.40% | 0.00% |
| March 1, 2024 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | A | Common Stock | 21755 | $0.00 | 55,960.0000 | 58,365,499 | 63.60% | 0.04% |
| March 1, 2024 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | A | Stock Option (Right to Buy) | 130531 | $0.00 | 130,531.0000 | 58,365,499 | 9999.99% | 0.22% |
| Feb. 9, 2024 | Compass Therapeutics, Inc. | $CMPX | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2024 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | S | Common Stock | 3295 | $22.58 | 34,205.0000 | 58,365,499 | 8.79% | 0.01% |
| Feb. 8, 2023 | Compass Therapeutics, Inc. | $CMPX | Chiniara Ellen | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | A | Common Stock | 37500 | $0.00 | 37,500.0000 | 53,933,229 | 9999.99% | 0.07% |
| Jan. 3, 2023 | Kymera Therapeutics, Inc. | $KYMR | Chiniara Ellen | Chief Legal Officer | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 53,933,229 | 9999.99% | 0.42% |